Stereotactic radiation can extend survival for latestage cancer patients
Stereotactic radiation can extend survival for late-stage cancer patients
“In this study, for patients with stage-IV disease, we have a treatment paradigm that can result in long-term survival while maintaining overall quality of life,” said senior author of the study, Dwight E. Heron, MD.
More From BioPortfolio on "Stereotactic radiation can extend survival for late-stage cancer patients"